BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15770010)

  • 21. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.
    Grau MV; Sandler RS; McKeown-Eyssen G; Bresalier RS; Haile RW; Barry EL; Ahnen DJ; Gui J; Summers RW; Baron JA
    J Natl Cancer Inst; 2009 Feb; 101(4):267-76. PubMed ID: 19211442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
    Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
    J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study of aspirin use and the risk for colorectal adenoma.
    Chan AT; Giovannucci EL; Schernhammer ES; Colditz GA; Hunter DJ; Willett WC; Fuchs CS
    Ann Intern Med; 2004 Feb; 140(3):157-66. PubMed ID: 14757613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma.
    Tranah GJ; Giovannucci E; Ma J; Fuchs C; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):863-70. PubMed ID: 15824157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized trial of aspirin to prevent colorectal adenomas.
    Baron JA; Cole BF; Sandler RS; Haile RW; Ahnen D; Bresalier R; McKeown-Eyssen G; Summers RW; Rothstein R; Burke CA; Snover DC; Church TR; Allen JI; Beach M; Beck GJ; Bond JH; Byers T; Greenberg ER; Mandel JS; Marcon N; Mott LA; Pearson L; Saibil F; van Stolk RU
    N Engl J Med; 2003 Mar; 348(10):891-9. PubMed ID: 12621133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium, vitamin D, and risk for colorectal adenoma: dependency on vitamin D receptor BsmI polymorphism and nonsteroidal anti-inflammatory drug use?
    Boyapati SM; Bostick RM; McGlynn KA; Fina MF; Roufail WM; Geisinger KR; Wargovich M; Coker A; Hebert JR
    Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):631-7. PubMed ID: 12869402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.
    Barry EL; Baron JA; Bhat S; Grau MV; Burke CA; Sandler RS; Ahnen DJ; Haile RW; O'Brien TG
    J Natl Cancer Inst; 2006 Oct; 98(20):1494-500. PubMed ID: 17047198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.
    Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS
    JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma.
    Chan AT; Hsu M; Zauber AG; Hawk ET; Bertagnolli MM
    Cancer Prev Res (Phila); 2012 Jan; 5(1):61-72. PubMed ID: 22030088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas.
    Giovannucci E; Chen J; Smith-Warner SA; Rimm EB; Fuchs CS; Palomeque C; Willett WC; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):970-9. PubMed ID: 14578131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin use and risk of colorectal cancer.
    Coogan PF; Smith J; Rosenberg L
    J Natl Cancer Inst; 2007 Jan; 99(1):32-40. PubMed ID: 17202111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective study of genetic polymorphisms in the cytochrome P-450 2C9 enzyme and the risk for distal colorectal adenoma.
    Chan AT; Tranah GJ; Giovannucci EL; Hunter DJ; Fuchs CS
    Clin Gastroenterol Hepatol; 2004 Aug; 2(8):704-12. PubMed ID: 15290664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regular use of aspirin and prostate cancer risk (United States).
    Menezes RJ; Swede H; Niles R; Moysich KB
    Cancer Causes Control; 2006 Apr; 17(3):251-6. PubMed ID: 16489532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women.
    Reeves MJ; Newcomb PA; Trentham-Dietz A; Storer BE; Remington PL
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):955-60. PubMed ID: 8959316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.
    Wei EK; Giovannucci E; Fuchs CS; Willett WC; Mantzoros CS
    J Natl Cancer Inst; 2005 Nov; 97(22):1688-94. PubMed ID: 16288122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.
    Barry EL; Poole EM; Baron JA; Makar KW; Mott LA; Sandler RS; Ahnen DJ; Bresalier RS; McKeown-Eyssen GE; Ulrich CM
    Cancer Causes Control; 2013 Jan; 24(1):47-54. PubMed ID: 23081681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States).
    Tangrea JA; Albert PS; Lanza E; Woodson K; Corle D; Hasson M; Burt R; Caan B; Paskett E; Iber F; Kikendall JW; Lance P; Shike M; Weissfeld J; Schatzkin A;
    Cancer Causes Control; 2003 Jun; 14(5):403-11. PubMed ID: 12946034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of regular aspirin use and breast cancer risk.
    Swede H; Mirand AL; Menezes RJ; Moysich KB
    Oncology; 2005; 68(1):40-7. PubMed ID: 15802928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.
    Barry EL; Sansbury LB; Grau MV; Ali IU; Tsang S; Munroe DJ; Ahnen DJ; Sandler RS; Saibil F; Gui J; Bresalier RS; McKeown-Eyssen GE; Burke C; Baron JA
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2726-33. PubMed ID: 19755647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial.
    Sansbury LB; Bergen AW; Wanke KL; Yu B; Caporaso NE; Chatterjee N; Ratnasinghe L; Schatzkin A; Lehman TA; Kalidindi A; Modali R; Lanza E
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):494-501. PubMed ID: 16537707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.